For new shareholders that had not seen thus, Charl
Post# of 148250
(Total Views: 420)
Posted On: 06/15/2019 7:53:25 PM
For new shareholders that had not seen thus, Charlie Sheen in 2017 talking about HIV drugs vs Pro 140. If monotherapy is approved, these stories will sell the drug.
He has not publicly said, that I have found, if he is still in the trial. He went silent publicly after this interview about pro 140, which made me speculate that he was asked not to talk about it publicly before it was approved. If so, it would be almost 3 years (back when he started only 325mg was available I believe).
Here is an interview last Nov 2018 that he said at 4m mark the technology is just aces, which leads me to believe he is still on it.
He has not publicly said, that I have found, if he is still in the trial. He went silent publicly after this interview about pro 140, which made me speculate that he was asked not to talk about it publicly before it was approved. If so, it would be almost 3 years (back when he started only 325mg was available I believe).
Here is an interview last Nov 2018 that he said at 4m mark the technology is just aces, which leads me to believe he is still on it.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼